Cargando…
A pilot study of IL-1 inhibition by anakinra in acute gout
Monosodium urate crystals stimulate monocytes and macrophages to release IL-1β through the NALP3 component of the inflammasome. The effectiveness of IL-1 inhibition in hereditary autoinflammatory syndromes with mutations in the NALP3 protein suggested that IL-1 inhibition might also be effective in...
Autores principales: | So, Alexander, De Smedt, Thibaut, Revaz, Sylvie, Tschopp, Jürg |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906806/ https://www.ncbi.nlm.nih.gov/pubmed/17352828 http://dx.doi.org/10.1186/ar2143 |
Ejemplares similares
-
IL1 inhibition in gout—where are we a decade on?
por: So, Alexander
Publicado: (2019) -
Patients Prescribed Anakinra for Acute Gout Have Baseline Increased Burden of Hyperuricemia, Tophi, and Comorbidities, and Ultimate All-Cause Mortality
por: Sharma, Ena, et al.
Publicado: (2019) -
Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
por: Maier, André, et al.
Publicado: (2015) -
Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011) -
Gout. Mechanisms of inflammation in gout
por: Busso, Nathalie, et al.
Publicado: (2010)